Strut Health review
Updated
NAD+ from $149, with refill terms to confirm and an open FDA letter
The FDA issued a warning letter to Strut Health, LLC dba Strut in February 2026 and the agency's index does not record it as closed out; Strut says nothing about it anywhere on its own site.
Starting at $149
FDA warning letter. The FDA issued a warning letter to Strut Health, LLC dba Strut in February 2026. The agency's index does not record it as closed out. You can look it up on the FDA’s warning-letter index.
We may earn a commission if you sign up through our links, at no cost to you. How we make money.
Key details
- Advertised price
- Starting at $149 for the NAD+ injection; tile states 500mg at 200mg/mL.
- Billing details
- The current product tile does not publish the billing period, full renewal terms or one-time alternative. Final pricing is determined after a complete consultation.
- Pharmacy
- Not named. Strut describes only "U.S. compounding pharmacies", with no 503A or 503B designation. The company itself is Strut Health, LLC of 701 Commerce St, Dallas TX, led by Simal Patel, MD, and it carries a LegitScript seal. That entity name matters on this page: it is the name on the FDA warning letter.
- Availability
- The current general FAQ says it ships to all states except Arkansas and cautions that some medications are unavailable in some states. Confirm NAD+-specific eligibility during intake.
- Comparison
- Listed on our NAD+ provider index.
Our verdict
Two facts belong at the top, and neither cancels the other. The FDA issued a warning letter to Strut Health, LLC dba Strut in February 2026, the index does not record it as closed out, and Strut makes no mention of it on its own site. Its current NAD+ tile publishes a $149 starting figure for a 500mg injection at 200mg/mL. Elsewhere the page describes 500–1000mg vials and says final pricing follows a completed consultation. The public product figure alone does not establish the refill frequency, next charge or one-time alternative. Ask for those details before creating a paid plan. Cancellation requires 48 hours before processing, and the refund policy makes a processed pharmacy order nonrefundable. The product page also retains a misleading peptide/pituitary description that does not describe NAD+.
NAD+ evidence
Compounded NAD+ is not an FDA-approved product, and the route sold here has no randomized human trial behind it: there is no published study showing that subcutaneous or intranasal NAD+ raises blood NAD+ in people, let alone that it improves energy, focus or any aging endpoint. What the clinical literature actually supports is the oral precursor NR, which does raise blood NAD+ in controlled trials — a different molecule by a different route. There is a specific reason to say this loudly on Strut's page: its own NAD+ page describes NAD+ as "a peptide that signals your own pituitary gland". NAD+ is not a peptide — it is a dinucleotide, containing no amino acids at all — and it does not act on the pituitary. That sentence is the sermorelin mechanism, and sermorelin's evidence, transplanted onto a molecule that has neither.
Pricing and fees
- Advertised price
- Starting at $149 for the NAD+ injection; tile states 500mg at 200mg/mL.
- Payment terms
- The current product tile does not publish the billing period, full renewal terms or one-time alternative. Final pricing is determined after a complete consultation.
- Pricing details
- Do not read the $149 tile as a verified flat monthly or auto-refill charge. Confirm the amount due now, supplied quantity, refill interval and next charge.
Additional fees
- Cancel subscriptions at least 48 hours before processing through the account
- No refund after the pharmacy processes an order, even before dispatch
- Report a defective or damaged item within two weeks of delivery
Prices are from Strut Health's own website and can change without notice.
Who it may suit
May suit you if
- You have read about the February 2026 warning letter and decided that is a risk you are prepared to carry
- You want the product tile to state an initial medication quantity
- You want online clinical review and account messaging
- You can review the actual charge and refill terms before ordering
Consider another option if
- You want a provider with no open FDA action attached to it — that is a sufficient reason on its own, and this site has alternatives
- You need the entire refill schedule priced on the public product page
- You want the NAD+ page to describe its ingredient correctly
- You need an assigned pharmacy named before starting intake
What’s included
- Consultation
- A completed online consultation is required before approval and final pricing. A separate consultation charge is not itemized on the current product page.
- Lab testing
- No universal NAD+-specific lab requirement or included testing panel is published on the current product page.
- Follow-up care
- The general FAQ advertises free unlimited doctor follow-ups and direct physician account messaging. Subscription changes, pauses and delays are available in the account; cancellation needs 48 hours before processing.
- Clinical support
- Direct physician messaging and free unlimited doctor follow-ups are advertised in the general FAQ. A dedicated nurse or coaching service is not described for NAD+.
- Supplies
- Not itemized on the NAD+ page.
- Shipping
- Not priced separately on the pages we read.
Limitations and policy details
The FDA issued a warning letter to Strut Health, LLC dba Strut in February 2026. It is on the agency's public record under that exact name, the close-out column against it is empty, and Strut discloses it nowhere on its own site. We won't characterize the agency's case — the letter is public, the index is linked from this page, and it makes its own case better than a paraphrase would — but its existence, its date and the fact that it is not closed out matter to anyone about to hand this company a payment and a medical history. The second knock is editorial. Strut's NAD+ page tells readers that NAD+ is "a peptide that signals your own pituitary gland to produce more of your own growth hormone." Every clause of that is wrong for NAD+ and correct for sermorelin, which Strut also sells. This is the how-it-works section of the product page, and it means the page selling you a 500 mg vial does not know what is in the vial.
Other considerations
- An FDA warning letter issued in February 2026 to Strut Health, LLC dba Strut sits on the agency's public record, and its close-out column is empty — the letter is not recorded as closed out
- Strut makes no disclosure of that letter anywhere on its own site
- The NAD+ page calls the coenzyme a peptide that signals the pituitary gland
- The starting tile does not establish the billing interval or next charge
- Pharmacy processing makes an order nonrefundable; cancellation needs 48-hour notice
- The actual dispensing pharmacy and its compounding class are not named
Cost calculators
How this site makes money
We may earn a commission when you buy a product or start care through our links, at no extra cost to you. Affiliate partners appear first in our provider comparison. Read the full disclosure.
Every figure on this page comes from Strut Health’s own site, and prices change without notice. Compare it against the rest of the field on our NAD+ provider index, or read every provider review.
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.